Insider · CIK 0001354345

Bolzon Bradley J PhD

Reports to the SEC for 8 companies · MENLO PARK, CA

sec.gov

Transactions

Companies

Filings

CIK

0001354345

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-06-09	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2021-07-19	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−700 sh	$128.71	−$90.1K	148,831
2021-07-19	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−1,324 sh	$127.36	−$169K	149,531
2021-07-19	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−3,504 sh	$125.67	−$440K	155,327
2021-07-19	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−4,472 sh	$126.41	−$565K	150,855
2021-06-29	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−7,981 sh	$149.47	−$1.19M	20,599
2021-06-29	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−6,646 sh	$151.24	−$1.01M	1,200
2021-06-29	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−1,400 sh	$145.92	−$204K	46,136
2021-06-29	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−1,200 sh	$152.42	−$183K	0
2021-06-29	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−12.2K sh	$148.58	−$1.81M	28,580
2021-06-29	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−600 sh	$146.69	−$88K	45,536
2021-06-29	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−12.8K sh	$150.49	−$1.92M	7,846
2021-06-29	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−4,780 sh	$147.43	−$705K	40,756
2021-06-28	CRSPCRISPR Therapeutics AGJ Other	Director	JOther	+6,018 sh	—	—	6,018
2021-06-28	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−4,519 sh	$153.54	−$694K	3,098
2021-06-28	CRSPCRISPR Therapeutics AGJ Other	Director	JOther	−6,018 sh	—	—	0
2021-06-28	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−2,218 sh	$153.54	−$341K	160,351
2021-06-28	CRSPCRISPR Therapeutics AGJ Other	Director	JOther	+847 sh	—	—	47,536
2021-06-28	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−3,139 sh	$152.38	−$478K	7,617
2021-06-28	CRSPCRISPR Therapeutics AGJ Other	Director	JOther	−27.9K sh	—	—	16,434
2021-06-28	CRSPCRISPR Therapeutics AGJ Other	Director	JOther	+79.1K sh	—	—	79,074
2021-06-28	CRSPCRISPR Therapeutics AGJ Other	Director	JOther	−3,650 sh	—	—	622
2021-06-28	CRSPCRISPR Therapeutics AGJ Other	Director	JOther	−84.1K sh	—	—	0
2021-06-28	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−1,578 sh	$150.65	−$238K	167,253
2021-06-28	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−3,144 sh	$151.49	−$476K	164,109
2021-06-28	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−6,403 sh	$151.49	−$970K	10,756
2021-06-28	GLUEMonte Rosa Therapeutics, Inc. · Series B convertible preferred stockC Conversion	Director, 10% Owner	CConversion	−4.15M sh	—	—	0
2021-06-28	GLUEMonte Rosa Therapeutics, Inc. · Series B convertible preferred stockC Conversion	Director, 10% Owner	CConversion	−3M sh	—	—	0
2021-06-28	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−1,540 sh	$152.38	−$235K	162,569
2021-06-28	GLUEMonte Rosa Therapeutics, Inc. · Series C convertible preferred stockC Conversion	Director, 10% Owner	CConversion	−2.7M sh	—	—	0
2021-06-28	CRSPCRISPR Therapeutics AGJ Other	Director	JOther	+27.7K sh	—	—	27,716
2021-06-28	GLUEMonte Rosa Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+1.94M sh	—	—	1,940,043
2021-06-28	CRSPCRISPR Therapeutics AGJ Other	Director	JOther	−616K sh	—	—	104,874
2021-06-28	CRSPCRISPR Therapeutics AGJ Other	Director	JOther	−11K sh	—	—	5,614
2021-06-28	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−268 sh	$155.27	−$41.6K	549
2021-06-28	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−132 sh	$155.27	−$20.5K	159,100
2021-06-28	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−549 sh	$156.54	−$85.9K	0
2021-06-28	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−1,119 sh	$154.57	−$173K	159,232
2021-06-28	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−269 sh	$156.54	−$42.1K	158,831
2021-06-28	CRSPCRISPR Therapeutics AGJ Other	Director	JOther	+19K sh	—	—	46,689
2021-06-28	CRSPCRISPR Therapeutics AGJ Other	Director	JOther	−159K sh	—	—	0
2021-06-28	CRSPCRISPR Therapeutics AGJ Other	Director	JOther	+159K sh	—	—	158,522
2021-06-28	GLUEMonte Rosa Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+6.52M sh	—	—	6,799,115
2021-06-28	GLUEMonte Rosa Therapeutics, Inc. · Series A convertible preferred stockC Conversion	Director, 10% Owner	CConversion	−20M sh	—	—	0
2021-06-28	GLUEMonte Rosa Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+158K sh	$19.00	+$3M	2,097,938
2021-06-28	CRSPCRISPR Therapeutics AGJ Other	Director	JOther	−366K sh	—	—	215,915
2021-06-28	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−3,216 sh	$150.65	−$484K	17,159
2021-06-28	CRSPCRISPR Therapeutics AGJ Other	Director	JOther	+2,378 sh	—	—	81,452
2021-06-28	CRSPCRISPR Therapeutics AGS Sale	Director	SSale	−2,281 sh	$154.57	−$353K	817
2021-06-28	CRSPCRISPR Therapeutics AGJ Other	Director	JOther	−12.2K sh	—	—	6,268

Recent filings

Accepted (ET)
Jun 104
Bolzon Bradley J PhD0001209191-22-036031
SEC(opens sec.gov)
Jul 214
Bolzon Bradley J PhD0000899243-21-029271
SEC(opens sec.gov)
Jun 304
Bolzon Bradley J PhD0000899243-21-026769
SEC(opens sec.gov)
Jun 304
Bolzon Bradley J PhD0000899243-21-026801
SEC(opens sec.gov)
Jun 304
Bolzon Bradley J PhD0000899243-21-026800
SEC(opens sec.gov)

Companies

Address

3000 SAND HILL RD., #4-210

MENLO PARK, CA, 94025